Nicotine induces dendritic spine remodeling in cultured hippocampal neurons

Journal of Neurochemistry

Volumn 128, Issue 2, 2014, Pages 246-255

  Oda, Akira ^a   Yamagata, Kanato ^b   Nakagomi, Saya ^c   Uejima, Hiroshi ^a   Wiriyasermkul, Pattama ^c   Ohgaki, Ryuichi ^c   Nagamori, Shushi ^c   Kanai, Yoshikatsu ^c   Tanaka, Hidekazu ^d  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

4 2; cultured hippocampal neurons; dendritic spine remodeling; glutamatergic neurotransmission; nAChR; nicotine; synaptic plasticity

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALPHA BUNGAROTOXIN; CALCIUM ION; DIHYDRO BETA ERYTHROIDINE; GLUTAMIC ACID; NICOTINE; NICOTINIC RECEPTOR ALPHA4BETA2; TETANUS TOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC SPINE; EXPOSURE; GENETIC TRANSFECTION; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA INTERFERENCE;

CULTURED HIPPOCAMPAL NEURONS; DENDRITIC SPINE REMODELING; GLUTAMATERGIC NEUROTRANSMISSION; NICOTINE; SYNAPTIC PLASTICITY; Α4Β2* NACHR;

ANIMALS; CELLS, CULTURED; DENDRITIC SPINES; GLUTAMATES; HIPPOCAMPUS; NEURONS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 84891833735     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12470     Document Type: Article

References (39)

1. Albuquerque E. X., Pereira E. F., Alkondon M., and, Rogers S. W., (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73-120.
2. Alkondon M., Pereira E. F., Barbosa C. T., and, Albuquerque E. X., (1997) Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283, 1396-1411.
3. Alkondon M., Pereira E. F., Almeida L. E., Randall W. R., and, Albuquerque E. X., (2000) Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 39, 2726-2739.
4. Ballesteros-Yanez I., Benavides-Piccione R., Bourgeois J. P., Changeux J. P., and, DeFelipe J., (2010) Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors. Proc. Natl Acad. Sci. USA 107, 11567-11572.
5. Benson D. L., Watkins F. H., Steward O., and, Banker G., (1994) Characterization of GABAergic neurons in hippocampal cell cultures. J. Neurocytol. 23, 279-295.
6. Champtiaux N., and, Changeux J. P., (2004) Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Prog. Brain Res. 145, 235-251.
7. Cheng S. B., Amici S. A., Ren X. Q., McKay S. B., Treuil M. W., Lindstrom J. M., Rao J., and, Anand R., (2009) Presynaptic targeting of alpha4beta2 nicotinic acetylcholine receptors is regulated by neurexin-1beta. J. Biol. Chem. 284, 23251-23259.
8. Dani J. A., and, De Biasi M., (2001) Cellular mechanisms of nicotine addiction. Pharmacol. Biochem. Behav. 70, 439-446.
9. Engert F., and, Bonhoeffer T., (1999) Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399, 66-70.
10. Frazier C. J., Buhler A. V., Weiner J. L., and, Dunwiddie T. V., (1998) Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 18, 8228-8235.
11. Fujii S., Ji Z., and, Sumikawa K., (2000) Inactivation of alpha7 ACh receptors and activation of non-alpha7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci. Lett. 286, 134-138.
12. Gan W. B., Grutzendler J., Wong W. T., Wong R. O., and, Lichtman J. W., (2000) Multicolor "DiOlistic" labeling of the nervous system using lipophilic dye combinations. Neuron 27, 219-225.
13. Gray R., Rajan A. S., Radcliffe K. A., Yakehiro M., and, Dani J. A., (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716.
14. Lang C., Barco A., Zablow L., Kandel E. R., Siegelbaum S. A., and, Zakharenko S. S., (2004) Transient expansion of synaptically connected dendritic spines upon induction of hippocampal long-term potentiation. Proc. Natl Acad. Sci. USA 101, 16665-16670.
15. Levin E. D., and, Rezvani A. H., (2000) Development of nicotinic drug therapy for cognitive disorders. Eur. J. Pharmacol. 393, 141-146.
16. Levin E. D., McClernon F. J., and, Rezvani A. H., (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 184, 523-539.
17. Lozada A. F., Wang X., Gounko N. V., Massey K. A., Duan J., Liu Z., and, Berg D. K., (2012) Induction of dendritic spines by beta2-containing nicotinic receptors. J. Neurosci. 32, 8391-8400.
18. Lu W., Man H., Ju W., Trimble W. S., MacDonald J. F., and, Wang Y. T., (2001) Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29, 243-254.
19. Matsuyama S., and, Matsumoto A., (2003) Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. J. Pharmacol. Sci. 93, 180-187.
20. Matsuzaki M., Honkura N., Ellis-Davies G. C., and, Kasai H., (2004) Structural basis of long-term potentiation in single dendritic spines. Nature 429, 761-766.
21. McGehee D. S., Heath M. J., Gelber S., Devay P., and, Role L. W., (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
22. Musleh W., Bi X., Tocco G., Yaghoubi S., and, Baudry M., (1997) Glycine-induced long-term potentiation is associated with structural and functional modifications of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. Proc. Natl Acad. Sci. USA 94, 9451-9456.
23. Nagai T., Ibata K., Park E. S., Kubota M., Mikoshiba K., and, Miyawaki A., (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87-90.
24. Nagerl U. V., Eberhorn N., Cambridge S. B., and, Bonhoeffer T., (2004) Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 44, 759-767.
25. Okamura K., Tanaka H., Yagita Y., Saeki Y., Taguchi A., Hiraoka Y., Zeng L. H., Colman D. R., and, Miki N., (2004) Cadherin activity is required for activity-induced spine remodeling. J. Cell Biol. 167, 961-972.
26. Otmakhov N., Khibnik L., Otmakhova N., Carpenter S., Riahi S., Asrican B., and, Lisman J., (2004) Forskolin-induced LTP in the CA1 hippocampal region is NMDA receptor dependent. J. Neurophysiol. 91, 1955-1962.
27. Quick M. W., and, Lester R. A., (2002) Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53, 457-478.
28. Rogers S. L., Farlow M. R., Doody R. S., Mohs R., and, Friedhoff L. T., (1998) A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 50, 136-145.
29. Rousseau S. J., Jones I. W., Pullar I. A., and, Wonnacott S., (2005) Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro. Neuropharmacology 49, 59-72.
30. Schafer M. K., Eiden L. E., and, Weihe E., (1998) Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience 84, 331-359.
31. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B. R., and, Montecucco C., (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832-835.
32. Sudweeks S. N., and, Yakel J. L., (2000) Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J. Physiol. 527 (Pt 3), 515-528.
33. Tanaka H., Shan W., Phillips G. R., Arndt K., Bozdagi O., Shapiro L., Huntley G. W., Benson D. L., and, Colman D. R., (2000) Molecular modification of N-cadherin in response to synaptic activity. Neuron 25, 93-107.
34. Toledano A., and, Alvarez M. I., (2004) Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models. Curr. Alzheimer Res. 1, 189-214.
35. Wess J., (2004) Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu. Rev. Pharmacol. Toxicol. 44, 423-450.
36. Xu J., Zhu Y., and, Heinemann S. F., (2006) Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons. J. Neurosci. 26, 9780-9793.
37. Yasuda S., Tanaka H., Sugiura H., et al,. (2007) Activity-induced protocadherin arcadlin regulates dendritic spine number by triggering N-cadherin endocytosis via TAO2beta and p38 MAP kinases. Neuron 56, 456-471.
38. Zarei M. M., Radcliffe K. A., Chen D., Patrick J. W., and, Dani J. A., (1999) Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons. Neuroscience 88, 755-764.
39. Zhou Q., Homma K. J., and, Poo M. M., (2004) Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses. Neuron 44, 749-757.